The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 5, 2025. CONSHOHOCKEN, Pa., January 02, 2025--Cencora, Inc. (NYSE: COR) today announced the completion of ...

Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (COR) is a leading pharmaceutical services company dedicated to ...

02月07日 14:38 美国连锁药店沃尔格林联合博姿(Walgreens Boots Alliance)周四表示，已出售更多药品分销商Cencora的股份，套现约3亿美元。该公司目前在Cencora ...

AmerisourceBergen Corp. plans to settle a proposed class action by workers who say the pharmaceutical company’s retirement ...

Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...

We believe Cencora is well positioned to enjoy these dynamics and expect it to maintain a leading position over our forecast period. The company has partnerships with some of the biggest customers ...

How can pharmaceutical firms shore up their sustainability credentials at a time when the entire research landscape is turning on its head? A recent webinar from supply chain leaders World Courier and ...

Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...

Cencora is updating its outlook for fiscal year 2025. The Company does not provide forward-looking guidance on a GAAP basis as discussed below in Fiscal Year 2025 Expectations. Adjusted diluted ...

Shares of Cencora Inc. COR slid 2.82% to $246.13 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to 6,083.57 and the ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive $300 million from an early settlement of some prepaid shares of Cencora along ...